Halozyme Therapeutics
HALO
YETI Holdings
YETI
eBay
EBAY
4
Collegium Pharmaceutical
COLL
5
Workday
WDAY
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 5.40%71.64M | 17.02%77.86M | 17.02%77.86M | 7.19%91.35M | 82.05%96.89M | 156.80%67.97M | 45.95%66.54M | 45.95%66.54M | 73.64%85.22M | -41.82%53.23M |
-Cash and cash equivalents | 5.40%71.64M | 17.02%77.86M | 17.02%77.86M | 7.19%91.35M | 82.05%96.89M | 156.80%67.97M | 45.95%66.54M | 45.95%66.54M | 73.64%85.22M | -41.82%53.23M |
Receivables | -5.71%497.08M | -8.18%314.86M | -8.18%314.86M | -7.78%425.69M | -8.47%577.53M | -6.56%527.18M | -2.43%342.91M | -2.43%342.91M | -16.04%461.58M | -16.61%630.95M |
-Accounts receivable | -2.68%146.21M | -48.38%31.47M | -48.38%31.47M | -15.22%119.54M | -16.52%169.85M | -7.86%150.24M | 85.91%60.97M | 85.91%60.97M | -25.47%141M | -15.10%203.46M |
-Other receivables | -6.92%350.87M | -0.57%291.98M | -0.57%291.98M | -4.50%306.16M | -4.63%407.68M | -6.03%376.94M | -10.52%293.66M | -10.52%293.66M | -11.10%320.59M | -17.30%427.49M |
-Recievables adjustments allowances | ---- | 26.67%-8.59M | 26.67%-8.59M | ---- | ---- | ---- | -23.06%-11.72M | -23.06%-11.72M | ---- | ---- |
Inventory | -2.42%1.46B | -5.58%1.29B | -5.58%1.29B | -6.26%1.18B | -6.98%1.3B | -11.25%1.5B | -14.18%1.37B | -14.18%1.37B | -18.20%1.26B | -11.79%1.39B |
Prepaid assets | ---- | 37.62%42.9M | 37.62%42.9M | ---- | ---- | ---- | 27.80%31.18M | 27.80%31.18M | ---- | ---- |
Other current assets | 8.21%48.18M | -54.83%4.19M | -54.83%4.19M | 63.43%43.17M | 79.00%35.79M | 59.72%44.52M | 42.64%9.27M | 42.64%9.27M | -56.72%26.41M | -53.84%19.99M |
Total current assets | -2.76%2.08B | -4.75%1.73B | -4.75%1.73B | -5.01%1.74B | -4.35%2.01B | -7.31%2.14B | -10.09%1.82B | -10.09%1.82B | -16.68%1.83B | -15.12%2.1B |
Non current assets | ||||||||||
Net PPE | 5.03%566.11M | 6.90%566.18M | 6.90%566.18M | 8.98%552.96M | 13.64%555.71M | 13.38%539.02M | 14.31%529.62M | 14.31%529.62M | 15.32%507.41M | 10.37%489.01M |
-Gross PPE | 5.03%566.11M | 7.68%821.33M | 7.68%821.33M | 8.98%552.96M | 13.64%555.71M | 13.38%539.02M | 13.03%762.75M | 13.03%762.75M | 15.32%507.41M | 10.37%489.01M |
-Accumulated depreciation | ---- | -9.44%-255.15M | -9.44%-255.15M | ---- | ---- | ---- | -10.22%-233.14M | -10.22%-233.14M | ---- | ---- |
Goodwill and other intangible assets | -0.79%988.02M | -0.87%989.64M | -0.87%989.64M | -0.66%992.87M | -0.80%994.37M | -0.11%995.92M | 0.09%998.36M | 0.09%998.36M | 0.03%999.51M | 0.00%1B |
-Goodwill | -0.02%699.25M | -0.17%698.91M | -0.17%698.91M | 0.13%700.15M | -0.03%699.69M | 0.89%699.42M | 1.17%700.08M | 1.17%700.08M | 1.08%699.27M | 1.00%699.92M |
-Other intangible assets | -2.61%288.77M | -2.53%290.73M | -2.53%290.73M | -2.50%292.72M | -2.57%294.68M | -2.39%296.49M | -2.35%298.28M | -2.35%298.28M | -2.33%300.24M | -2.24%302.44M |
Investments and advances | 11.93%1.51M | 10.27%1.44M | 10.27%1.44M | 3.69%1.43M | 9.47%1.4M | 11.94%1.35M | 4.57%1.31M | 4.57%1.31M | 16.22%1.38M | 8.40%1.28M |
Other non current assets | -7.79%79.23M | -1.93%81.81M | -1.93%81.81M | -11.66%79.43M | -7.98%83.62M | 2.29%85.93M | -1.20%83.43M | -1.20%83.43M | 86.50%89.92M | 101.75%90.88M |
Total non current assets | 0.78%1.63B | 1.63%1.64B | 1.63%1.64B | 1.78%1.63B | 3.26%1.64B | 4.15%1.62B | 4.28%1.61B | 4.28%1.61B | 7.37%1.6B | 6.16%1.58B |
Total assets | -1.23%3.71B | -1.75%3.37B | -1.75%3.37B | -1.85%3.37B | -1.08%3.64B | -2.69%3.76B | -3.85%3.43B | -3.85%3.43B | -6.98%3.43B | -7.11%3.68B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -1.94%890.17M | 15.70%613.08M | 15.70%613.08M | -6.46%401.7M | 6.30%515.65M | 22.72%907.81M | 25.22%529.88M | 25.22%529.88M | -2.89%429.44M | -19.72%485.1M |
-accounts payable | -1.94%890.17M | 3.26%525.24M | 3.26%525.24M | -6.46%401.7M | 6.30%515.65M | 22.72%907.81M | 25.08%508.67M | 25.08%508.67M | -2.89%429.44M | -19.72%485.1M |
-Total tax payable | ---- | 314.20%87.85M | 314.20%87.85M | ---- | ---- | ---- | 28.70%21.21M | 28.70%21.21M | ---- | ---- |
Current accrued expenses | 10.38%109.89M | -18.92%18.96M | -18.92%18.96M | 17.78%185.12M | -10.36%152.98M | -21.04%99.56M | 4.75%23.38M | 4.75%23.38M | -25.32%157.17M | -12.72%170.66M |
Current debt and capital lease obligation | 22.47%157.76M | 15.96%147.76M | 15.96%147.76M | 14.35%140.1M | 19.63%138.75M | 15.45%128.82M | 26.75%127.42M | 26.75%127.42M | 44.84%122.51M | 27.06%115.98M |
-Current debt | 55.66%57.06M | 29.50%49.47M | 29.50%49.47M | 18.25%44.68M | 23.49%44.73M | 10.81%36.66M | 52.56%38.2M | 52.56%38.2M | 209.53%37.79M | 83.56%36.22M |
-Current capital lease obligation | 9.26%100.7M | 10.17%98.28M | 10.17%98.28M | 12.62%95.41M | 17.88%94.02M | 17.41%92.16M | 18.19%89.22M | 18.19%89.22M | 17.06%84.72M | 11.48%79.76M |
Other current liabilities | ---- | -22.87%46.08M | -22.87%46.08M | ---- | ---- | ---- | 1.06%59.74M | 1.06%59.74M | ---- | ---- |
Current liabilities | 1.90%1.16B | 9.53%844.19M | 9.53%844.19M | 2.51%726.92M | 4.62%807.37M | 16.24%1.14B | 14.07%770.77M | 14.07%770.77M | -3.82%709.12M | -13.39%771.74M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 2.07%1.19B | -9.13%1.12B | -9.13%1.12B | -9.17%1.1B | -4.05%1.3B | -24.00%1.17B | -20.72%1.24B | -20.72%1.24B | -28.30%1.21B | -23.46%1.35B |
-Long term debt | 2.71%968.03M | -11.25%900.88M | -11.25%900.88M | -11.74%879.15M | -6.67%1.07B | -29.28%942.52M | -25.46%1.02B | -25.46%1.02B | -33.61%996.11M | -27.12%1.15B |
-Long term capital lease obligation | -0.65%221.29M | 0.60%223.28M | 0.60%223.28M | 2.77%220.1M | 10.64%226.32M | 11.09%222.73M | 11.79%221.95M | 11.79%221.95M | 14.17%214.17M | 6.62%204.55M |
Non current deferred liabilities | 17.77%81.15M | 20.75%81.41M | 20.75%81.41M | 17.89%65.11M | 16.24%67.6M | 19.07%68.9M | 14.74%67.42M | 14.74%67.42M | 22.05%55.23M | 37.21%58.15M |
Other non current liabilities | 6.23%45.47M | 12.32%44.96M | 12.32%44.96M | 15.12%43.61M | 12.49%44.14M | 13.78%42.81M | 12.85%40.03M | 12.85%40.03M | 41.66%37.89M | 22.20%39.24M |
Total non current liabilities | 3.05%1.32B | -6.99%1.25B | -6.99%1.25B | -7.32%1.21B | -2.79%1.41B | -21.59%1.28B | -18.74%1.34B | -18.74%1.34B | -25.94%1.3B | -21.27%1.45B |
Total liabilities | 2.51%2.47B | -0.97%2.09B | -0.97%2.09B | -3.86%1.93B | -0.22%2.22B | -7.40%2.41B | -9.22%2.12B | -9.22%2.12B | -19.41%2.01B | -18.70%2.22B |
Shareholders'equity | ||||||||||
Share capital | 0.00%38K | 0.00%38K | 0.00%38K | -2.56%38K | -2.56%38K | -2.56%38K | -2.56%38K | -2.56%38K | 0.00%39K | -2.50%39K |
-common stock | 0.00%38K | 0.00%38K | 0.00%38K | -2.56%38K | -2.56%38K | -2.56%38K | -2.56%38K | -2.56%38K | 0.00%39K | -2.50%39K |
Retained earnings | -16.66%600.25M | -7.36%648.48M | -7.36%648.48M | -1.12%802.38M | -6.59%798.2M | 8.21%720.23M | 7.12%699.99M | 7.12%699.99M | 30.73%811.43M | 28.95%854.56M |
Paid-in capital | 4.96%651.05M | 5.35%638.62M | 5.35%638.62M | 5.42%632.52M | 5.61%626.35M | 5.74%620.28M | 5.28%606.18M | 5.28%606.18M | 5.11%600.01M | 5.04%593.08M |
Gains losses not affecting retained earnings | -346.07%-12.65M | -307.60%-13.66M | -307.60%-13.66M | -136.05%-2.43M | -108.48%-920K | 12.84%5.14M | 11.65%6.58M | 11.65%6.58M | 1,052.54%6.74M | 550.66%10.85M |
Total stockholders'equity | -7.95%1.24B | -3.00%1.27B | -3.00%1.27B | 1.01%1.43B | -2.39%1.42B | 7.08%1.35B | 6.28%1.31B | 6.28%1.31B | 19.09%1.42B | 18.67%1.46B |
Total equity | -7.95%1.24B | -3.00%1.27B | -3.00%1.27B | 1.01%1.43B | -2.39%1.42B | 7.08%1.35B | 6.28%1.31B | 6.28%1.31B | 19.09%1.42B | 18.67%1.46B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |